Zenas Biopharma (NASDAQ:ZBIO) Earns Outperform Rating from Analysts at Wedbush
Equities research analysts at Wedbush initiated coverage on shares of Zenas Biopharma (NASDAQ:ZBIO – Get Free Report) in a research note issued on Thursday, Marketbeat Ratings reports. The brokerage set an “outperform” rating and a $35.00 price target on the stock. Wedbush’s target price would suggest a potential upside of 320.17% from the company’s previous […]
Equities research analysts at Wedbush initiated coverage on shares of Zenas Biopharma (NASDAQ:ZBIO – Get Free Report) in a research note issued on Thursday, Marketbeat Ratings reports. The brokerage set an “outperform” rating and a $35.00 price target on the stock. Wedbush’s target price would suggest a potential upside of 320.17% from the company’s previous […]
